Jonathan Tickner

CAT rules in favour of NHS in significant competition claim against pharmaceuticals

Hélène Préchac June 24, 2024 0 Comments

Peters & Peters was recently instructed to act for the NHS in long-running litigation against the Danish pharmaceutical company Lundbeck and several others, and to seek to resist arguments by the pharmaceutical companies that the NHS’ claim had been brought out of time and should not be allowed to proceed. The claims arise from the […]

READ MORE
Colbalt Blue Ampersand Crop (Left)

Extraterritorial powers for the CMA?

Hélène Préchac March 26, 2024 0 Comments

Can the Competition Markets Authority (CMA) compel overseas companies to give it information? This was the question at the centre of the recent case of Competition and Markets Authority v Rex on the application of Volkswagen Aktiengesellschaft. Here, the Court of Appeal allowed the CMA’s appeal against a decision that had denied it the ability […]

READ MORE